News
VRCI
0.0000
NaN%
--
Weekly Report: what happened at VRCI last week (0608-0612)?
Weekly Report · 58m ago
Weekly Report: what happened at VRCI last week (0601-0605)?
Weekly Report · 06/08 09:21
Weekly Report: what happened at VRCI last week (0525-0529)?
Weekly Report · 06/01 09:23
Weekly Report: what happened at VRCI last week (0518-0522)?
Weekly Report · 05/25 09:24
Weekly Report: what happened at VRCI last week (0511-0515)?
Weekly Report · 05/18 09:24
Weekly Report: what happened at VRCI last week (0504-0508)?
Weekly Report · 05/11 09:23
Weekly Report: what happened at VRCI last week (0427-0501)?
Weekly Report · 05/04 09:22
Weekly Report: what happened at VRCI last week (0420-0424)?
Weekly Report · 04/27 09:23
Weekly Report: what happened at VRCI last week (0413-0417)?
Weekly Report · 04/20 09:21
Weekly Report: what happened at VRCI last week (0406-0410)?
Weekly Report · 04/13 09:23
Weekly Report: what happened at VRCI last week (0330-0403)?
Weekly Report · 04/06 09:23
Weekly Report: what happened at VRCI last week (0323-0327)?
Weekly Report · 03/30 09:23
Weekly Report: what happened at VRCI last week (0316-0320)?
Weekly Report · 03/23 09:22
Weekly Report: what happened at VRCI last week (0309-0313)?
Weekly Report · 03/16 09:21
Weekly Report: what happened at VRCI last week (0302-0306)?
Weekly Report · 03/09 09:22
Weekly Report: what happened at VRCI last week (0223-0227)?
Weekly Report · 03/02 09:22
Weekly Report: what happened at VRCI last week (0216-0220)?
Weekly Report · 02/23 09:21
Weekly Report: what happened at VRCI last week (0209-0213)?
Weekly Report · 02/16 09:21
Weekly Report: what happened at VRCI last week (0202-0206)?
Weekly Report · 02/09 09:22
Weekly Report: what happened at VRCI last week (0126-0130)?
Weekly Report · 02/02 09:22
More
Webull provides a variety of real-time VRCI stock news. You can receive the latest news about Verde Science through multiple platforms. This information may help you make smarter investment decisions.
About VRCI
Verde Science, Inc. is a pharmaceutical research and development company. The Company is engaged in medical science consulting business. The Company is focused on the discovery of drugs and treatment modalities, as well as diagnostic devices and pharmaceutical delivery systems for the treatment of diseases and medical issues. The Company is focused on developing medicinal formulations from cannabinoids and tetrahydrocannabinol (THC) compounds for the treatment of various issues, such as migraines, glaucoma, loss of appetite from cancer therapies, and other medical issues. The Company is focused on launching its THC Pharmaceutical Development Program by executing a research program, which involves developing formulations preparing protocols for clinical trials.